Aquestive Therapeutics In... (AQST)
NASDAQ: AQST
· Real-Time Price · USD
5.42
0.36 (7.11%)
At close: Sep 05, 2025, 3:59 PM
5.39
-0.55%
After-hours: Sep 05, 2025, 07:56 PM EDT
Aquestive Therapeutics Revenue
Aquestive Therapeutics reported an annual revenue of $57.56M, reflecting a 13.8% growth. For the quarter ending June 30, 2025, Aquestive Therapeutics generated $10M in revenue.
Revenue (ttm)
57.56M
Revenue Growth
13.8%
Price / Sales Ratio
5.36
Revenue / Employee
405.36K
Employees
142
Market Cap
540.54M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 57.56M | +13.80% |
| Dec 31, 2023 | 50.58M | +6.09% |
| Dec 31, 2022 | 47.68M | -6.20% |
| Dec 31, 2021 | 50.83M | +10.87% |
| Dec 31, 2020 | 45.85M | -12.85% |
| Dec 31, 2019 | 52.61M | -21.98% |
| Dec 31, 2018 | 67.43M | +0.77% |
| Dec 31, 2017 | 66.92M | +29.22% |
| Dec 31, 2016 | 51.78M | n/a |